Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Sep 15;98(6):1324–1331. doi: 10.1172/JCI118919

Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice.

M G von Herrath 1, T Dyrberg 1, M B Oldstone 1
PMCID: PMC507558  PMID: 8823297

Abstract

Oral administration of self-antigens has been proposed as a therapy to prevent and treat autoimmune diseases. Here we report that oral treatment with insulin prevents virus-induced insulin-dependent diabetes mellitus (IDDM) in a transgenic (tg) mouse model. Such mice express the viral nucleoprotein (NP) of lymphocytic choriomeningitis virus (LCMV) under control of the rat insulin promoter in their pancreatic beta cells and < 2% spontaneously develop diabetes. However, 2 mo after challenge with LCMV, IDDM occurs in > 95% of tg mice but not in controls. Oral treatment with 1 mg of insulin twice per week for 2 mo starting either 1 wk before or 10 d after initiating LCMV infection prevents IDDM in > 50% of the tg mice (observation time 8 mo). Thus, insulin therapy is effective in preventing progression to overt IDDM in prediabetic tg mice with ongoing islet infiltration. Oral administration of insulin does not affect the generation of LCMV-NP-specific anti-self cytotoxic T lymphocytes nor the infiltration of lymphocytes into the pancreas. However, less beta cells are destroyed in insulin-treated mice, upregulation of MHC class I and II molecules does not occur, and antiviral (self) cytotoxic T lymphocytes are not found in the islets, events present in tg mice developing IDDM. The majority of lymphocytes in the islets of insulin-treated tg mice without IDDM produces IL-4, IL-10, and TGF-beta. In contrast, lymphocytes from islets of tg mice developing IDDM mainly make gamma-IFN.

Full Text

The Full Text of this article is available as a PDF (9.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aichele P., Kyburz D., Ohashi P. S., Odermatt B., Zinkernagel R. M., Hengartner H., Pircher H. Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):444–448. doi: 10.1073/pnas.91.2.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Atkinson M. A., Bowman M. A., Campbell L., Darrow B. L., Kaufman D. L., Maclaren N. K. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest. 1994 Nov;94(5):2125–2129. doi: 10.1172/JCI117567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Atkinson M. A., Kaufman D. L., Newman D., Tobin A. J., Maclaren N. K. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J Clin Invest. 1993 Jan;91(1):350–356. doi: 10.1172/JCI116192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bach J. F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev. 1994 Aug;15(4):516–542. doi: 10.1210/edrv-15-4-516. [DOI] [PubMed] [Google Scholar]
  5. Bowman M. A., Leiter E. H., Atkinson M. A. Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease. Immunol Today. 1994 Mar;15(3):115–120. doi: 10.1016/0167-5699(94)90154-6. [DOI] [PubMed] [Google Scholar]
  6. Chen Y., Inobe J., Marks R., Gonnella P., Kuchroo V. K., Weiner H. L. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature. 1995 Jul 13;376(6536):177–180. doi: 10.1038/376177a0. [DOI] [PubMed] [Google Scholar]
  7. Chen Y., Inobe J., Weiner H. L. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression. J Immunol. 1995 Jul 15;155(2):910–916. [PubMed] [Google Scholar]
  8. Chen Y., Kuchroo V. K., Inobe J., Hafler D. A., Weiner H. L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 1994 Aug 26;265(5176):1237–1240. doi: 10.1126/science.7520605. [DOI] [PubMed] [Google Scholar]
  9. Cooke A., Mandell T. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. J Endocrinol Invest. 1994 Jul-Aug;17(7):585–593. doi: 10.1007/BF03347754. [DOI] [PubMed] [Google Scholar]
  10. Eisenbarth G. S. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med. 1986 May 22;314(21):1360–1368. doi: 10.1056/NEJM198605223142106. [DOI] [PubMed] [Google Scholar]
  11. Fontana A., Constam D. B., Frei K., Malipiero U., Pfister H. W. Modulation of the immune response by transforming growth factor beta. Int Arch Allergy Immunol. 1992;99(1):1–7. doi: 10.1159/000236328. [DOI] [PubMed] [Google Scholar]
  12. Garside P., Steel M., Liew F. Y., Mowat A. M. CD4+ but not CD8+ T cells are required for the induction of oral tolerance. Int Immunol. 1995 Mar;7(3):501–504. doi: 10.1093/intimm/7.3.501. [DOI] [PubMed] [Google Scholar]
  13. Hagopian W. A., Sanjeevi C. B., Kockum I., Landin-Olsson M., Karlsen A. E., Sundkvist G., Dahlquist G., Palmer J., Lernmark A. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest. 1995 Apr;95(4):1505–1511. doi: 10.1172/JCI117822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hancock W. W., Polanski M., Zhang J., Blogg N., Weiner H. L. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E. Am J Pathol. 1995 Nov;147(5):1193–1199. [PMC free article] [PubMed] [Google Scholar]
  15. Hancock W. W., Polanski M., Zhang J., Blogg N., Weiner H. L. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E. Am J Pathol. 1995 Nov;147(5):1193–1199. [PMC free article] [PubMed] [Google Scholar]
  16. Ivashkiv L. B. Cytokines and STATs: how can signals achieve specificity? Immunity. 1995 Jul;3(1):1–4. doi: 10.1016/1074-7613(95)90152-3. [DOI] [PubMed] [Google Scholar]
  17. Katz J. D., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Science. 1995 May 26;268(5214):1185–1188. doi: 10.1126/science.7761837. [DOI] [PubMed] [Google Scholar]
  18. Kaufman D. L., Clare-Salzler M., Tian J., Forsthuber T., Ting G. S., Robinson P., Atkinson M. A., Sercarz E. E., Tobin A. J., Lehmann P. V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 1993 Nov 4;366(6450):69–72. doi: 10.1038/366069a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lamont A. Are we closer to selective immunotherapy for autoimmune diseases? Immunol Today. 1994 Feb;15(2):45–47. doi: 10.1016/0167-5699(94)90130-9. [DOI] [PubMed] [Google Scholar]
  20. Larger E., Bécourt C., Bach J. F., Boitard C. Pancreatic islet beta cells drive T cell-immune responses in the nonobese diabetic mouse model. J Exp Med. 1995 May 1;181(5):1635–1642. doi: 10.1084/jem.181.5.1635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lee M. S., Wogensen L., Shizuru J., Oldstone M. B., Sarvetnick N. Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J Clin Invest. 1994 Mar;93(3):1332–1338. doi: 10.1172/JCI117092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lee M. S., von Herrath M., Reiser H., Oldstone M. B., Sarvetnick N. Sensitization to self (virus) antigen by in situ expression of murine interferon-gamma. J Clin Invest. 1995 Feb;95(2):486–492. doi: 10.1172/JCI117689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Liblau R. S., Singer S. M., McDevitt H. O. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today. 1995 Jan;16(1):34–38. doi: 10.1016/0167-5699(95)80068-9. [DOI] [PubMed] [Google Scholar]
  24. Miller A., Lider O., Roberts A. B., Sporn M. B., Weiner H. L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):421–425. doi: 10.1073/pnas.89.1.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ohashi P. S., Oehen S., Buerki K., Pircher H., Ohashi C. T., Odermatt B., Malissen B., Zinkernagel R. M., Hengartner H. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 1991 Apr 19;65(2):305–317. doi: 10.1016/0092-8674(91)90164-t. [DOI] [PubMed] [Google Scholar]
  26. Oldstone M. B., Nerenberg M., Southern P., Price J., Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell. 1991 Apr 19;65(2):319–331. doi: 10.1016/0092-8674(91)90165-u. [DOI] [PubMed] [Google Scholar]
  27. Panina-Bordignon P., Lang R., van Endert P. M., Benazzi E., Felix A. M., Pastore R. M., Spinas G. A., Sinigaglia F. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med. 1995 May 1;181(5):1923–1927. doi: 10.1084/jem.181.5.1923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Petersen J. S., Dyrberg T., Karlsen A. E., Mølvig J., Michelsen B., Nerup J., Mandrup-Poulsen T. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group. Diabetes. 1994 Nov;43(11):1291–1296. doi: 10.2337/diab.43.11.1291. [DOI] [PubMed] [Google Scholar]
  29. Petersen J. S., Hejnaes K. R., Moody A., Karlsen A. E., Marshall M. O., Høier-Madsen M., Boel E., Michelsen B. K., Dyrberg T. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes. 1994 Mar;43(3):459–467. doi: 10.2337/diab.43.3.459. [DOI] [PubMed] [Google Scholar]
  30. Schatz D., Krischer J., Horne G., Riley W., Spillar R., Silverstein J., Winter W., Muir A., Derovanesian D., Shah S. Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. J Clin Invest. 1994 Jun;93(6):2403–2407. doi: 10.1172/JCI117247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tisch R., McDevitt H. O. Antigen-specific immunotherapy: is it a real possibility to combat T-cell-mediated autoimmunity? Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):437–438. doi: 10.1073/pnas.91.2.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Tisch R., Yang X. D., Singer S. M., Liblau R. S., Fugger L., McDevitt H. O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 1993 Nov 4;366(6450):72–75. doi: 10.1038/366072a0. [DOI] [PubMed] [Google Scholar]
  33. Trentham D. E., Dynesius-Trentham R. A., Orav E. J., Combitchi D., Lorenzo C., Sewell K. L., Hafler D. A., Weiner H. L. Effects of oral administration of type II collagen on rheumatoid arthritis. Science. 1993 Sep 24;261(5129):1727–1730. doi: 10.1126/science.8378772. [DOI] [PubMed] [Google Scholar]
  34. Wegmann D. R., Gill R. G., Norbury-Glaser M., Schloot N., Daniel D. Analysis of the spontaneous T cell response to insulin in NOD mice. J Autoimmun. 1994 Dec;7(6):833–843. doi: 10.1006/jaut.1994.1066. [DOI] [PubMed] [Google Scholar]
  35. Weiner H. L., Friedman A., Miller A., Khoury S. J., al-Sabbagh A., Santos L., Sayegh M., Nussenblatt R. B., Trentham D. E., Hafler D. A. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol. 1994;12:809–837. doi: 10.1146/annurev.iy.12.040194.004113. [DOI] [PubMed] [Google Scholar]
  36. Weiner H. L., Mackin G. A., Matsui M., Orav E. J., Khoury S. J., Dawson D. M., Hafler D. A. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science. 1993 Feb 26;259(5099):1321–1324. doi: 10.1126/science.7680493. [DOI] [PubMed] [Google Scholar]
  37. Weiner H. L. Oral tolerance: mobilizing the gut. Hosp Pract (1995) 1995 Sep 15;30(9):53–58. doi: 10.1080/21548331.1995.11443258. [DOI] [PubMed] [Google Scholar]
  38. Whitacre C. C., Gienapp I. E., Orosz C. G., Bitar D. M. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol. 1991 Oct 1;147(7):2155–2163. [PubMed] [Google Scholar]
  39. Whitton J. L., Gebhard J. R., Lewicki H., Tishon A., Oldstone M. B. Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus. J Virol. 1988 Mar;62(3):687–695. doi: 10.1128/jvi.62.3.687-695.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Whitton J. L., Southern P. J., Oldstone M. B. Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology. 1988 Feb;162(2):321–327. doi: 10.1016/0042-6822(88)90471-0. [DOI] [PubMed] [Google Scholar]
  41. von Herrath M. G., Allison J., Miller J. F., Oldstone M. B. Focal expression of interleukin-2 does not break unresponsiveness to "self" (viral) antigen expressed in beta cells but enhances development of autoimmune disease (diabetes) after initiation of an anti-self immune response. J Clin Invest. 1995 Feb;95(2):477–485. doi: 10.1172/JCI117688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. von Herrath M. G., Dockter J., Nerenberg M., Gairin J. E., Oldstone M. B. Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus. J Exp Med. 1994 Nov 1;180(5):1901–1910. doi: 10.1084/jem.180.5.1901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. von Herrath M. G., Dockter J., Oldstone M. B. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity. 1994 Jun;1(3):231–242. doi: 10.1016/1074-7613(94)90101-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES